# Comstock Inc.: financial statements, quarterly

LODE · NYSE · CIK 1120970 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lode.md) · [Financials](/companies/lode/financials.md) · [Filings](/companies/lode/filings.md) · [Insiders](/companies/lode/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lode/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.8](/filings/0001120970-23-000072.md) | [0.4 d](/filings/0001120970-24-000014.md) | [0.4](/filings/0001120970-24-000044.md) | [0.4](/filings/0001437749-25-026942.md) | [0.6](/filings/0001437749-25-032230.md) | [1.6 d](/filings/0001437749-26-009589.md) | [0.8](/filings/0001437749-26-015573.md) | [0.3](/filings/0001437749-26-024304.md) | [0.1](/filings/0001437749-25-032230.md) | [0.4 d](/filings/0001437749-26-009589.md) | [0.3](/filings/0001437749-26-015573.md) | [0.3](/filings/0001437749-26-024304.md) |
| Cost of revenue | $m | not reported | not reported | [0.0](/filings/0001437749-25-015474.md) | [0.0](/filings/0001437749-25-026942.md) | [0.0](/filings/0001437749-25-032230.md) | [0.5 d](/filings/0001437749-26-009589.md) | [0.9](/filings/0001437749-26-015573.md) | [0.8](/filings/0001437749-26-024304.md) | [0.3](/filings/0001437749-25-032230.md) | [0.6 d](/filings/0001437749-26-009589.md) | [0.6](/filings/0001437749-26-015573.md) | [1.2](/filings/0001437749-26-024304.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [1.4](/filings/0001437749-24-031673.md) | [1.7 d](/filings/0001437749-25-006453.md) | [0.9](/filings/0001437749-25-015474.md) | [2.5](/filings/0001437749-25-026942.md) | [1.4](/filings/0001437749-25-032230.md) | [14.2 d](/filings/0001437749-26-009589.md) | [3.3](/filings/0001437749-26-015573.md) | [2.1](/filings/0001437749-26-024304.md) | [2.2](/filings/0001437749-25-032230.md) | [4.7 d](/filings/0001437749-26-009589.md) | [2.1](/filings/0001437749-26-015573.md) | [2.3](/filings/0001437749-26-024304.md) |
| Selling, general and administrative | $m | [3.1](/filings/0001437749-24-031673.md) | [2.6 d](/filings/0001437749-25-006453.md) | [3.5](/filings/0001437749-25-015474.md) | [2.8](/filings/0001437749-25-026942.md) | [3.2](/filings/0001437749-25-032230.md) | [3.2 d](/filings/0001437749-26-009589.md) | [3.3](/filings/0001437749-26-015573.md) | [4.6](/filings/0001437749-26-024304.md) | [6.1](/filings/0001437749-25-032230.md) | [6.7 d](/filings/0001437749-26-009589.md) | [6.6](/filings/0001437749-26-015573.md) | [7.3](/filings/0001437749-26-024304.md) |
| Operating income | $m | [2.7](/filings/0001437749-24-031673.md) | [(4.3) d](/filings/0001437749-25-006453.md) | [(4.6)](/filings/0001437749-25-015474.md) | [(5.6)](/filings/0001437749-25-026942.md) | [(13.6)](/filings/0001437749-25-032230.md) | [(15.8) d](/filings/0001437749-26-009589.md) | [(7.0)](/filings/0001437749-26-015573.md) | [(7.7)](/filings/0001437749-26-024304.md) | [(10.2)](/filings/0001437749-25-032230.md) | [(13.2) d](/filings/0001437749-26-009589.md) | [(8.9)](/filings/0001437749-26-015573.md) | [(26.9)](/filings/0001437749-26-024304.md) |
| Interest expense | $m | [0.3](/filings/0001120970-23-000072.md) | [0.3 d](/filings/0001120970-24-000014.md) | [0.8](/filings/0001120970-24-000044.md) | [0.8](/filings/0001437749-25-026942.md) | [0.7](/filings/0001437749-25-032230.md) | [0.7 d](/filings/0001437749-26-009589.md) | [0.7](/filings/0001437749-26-015573.md) | [0.8](/filings/0001437749-26-024304.md) | [0.3](/filings/0001437749-25-032230.md) | [0.2 d](/filings/0001437749-26-009589.md) | [0.1](/filings/0001437749-26-015573.md) | [0.2](/filings/0001437749-26-024304.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [12.4](/filings/0001437749-24-031673.md) | [7.9 d](/filings/0001437749-25-006453.md) | [(6.9)](/filings/0001437749-25-015474.md) | [(8.6)](/filings/0001437749-25-026942.md) | [(15.0)](/filings/0001437749-25-032230.md) | [(22.8) d](/filings/0001437749-26-009589.md) | [(9.1)](/filings/0001437749-26-015573.md) | [(7.8)](/filings/0001437749-26-024304.md) | [(12.9)](/filings/0001437749-25-032230.md) | [(13.3) d](/filings/0001437749-26-009589.md) | [(9.4)](/filings/0001437749-26-015573.md) | [(25.5)](/filings/0001437749-26-024304.md) |
| Diluted EPS | $ per share | [0.11](/filings/0001437749-24-031673.md) | not reported | [(0.06)](/filings/0001120970-24-000044.md) | not reported | [(0.08)](/filings/0001437749-24-031673.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [0.11](/filings/0001437749-24-031673.md) | not reported | [(0.59)](/filings/0001437749-25-015474.md) | [(0.60)](/filings/0001437749-25-026942.md) | [(0.80)](/filings/0001437749-25-032230.md) | not reported | [(0.37)](/filings/0001437749-26-015573.md) | [(0.27)](/filings/0001437749-26-024304.md) | [(0.31)](/filings/0001437749-25-032230.md) | not reported | [(0.14)](/filings/0001437749-26-015573.md) | [(0.34)](/filings/0001437749-26-024304.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.4](/filings/0001120970-23-000072.md) | [3.8](/filings/0001437749-25-006453.md) | [0.5](/filings/0001120970-24-000044.md) | [0.1](/filings/0001437749-24-025555.md) | [1.4](/filings/0001437749-24-031673.md) | [1.0](/filings/0001437749-26-009589.md) | [17.0](/filings/0001437749-26-015573.md) | [18.6](/filings/0001437749-25-026942.md) | [31.7](/filings/0001437749-25-032230.md) | [17.0](/filings/0001437749-26-024304.md) | [53.0](/filings/0001437749-26-015573.md) | [31.4](/filings/0001437749-26-024304.md) |
| Current assets | $m | [30.7](/filings/0001120970-23-000072.md) | [23.2](/filings/0001437749-25-006453.md) | [22.1](/filings/0001120970-24-000044.md) | [28.4](/filings/0001437749-24-025555.md) | [29.9](/filings/0001437749-24-031673.md) | [12.6](/filings/0001437749-26-009589.md) | [20.7](/filings/0001437749-26-015573.md) | [23.0](/filings/0001437749-25-026942.md) | [35.1](/filings/0001437749-25-032230.md) | [20.7](/filings/0001437749-26-024304.md) | [77.0](/filings/0001437749-26-015573.md) | [58.1](/filings/0001437749-26-024304.md) |
| Total assets | $m | [106](/filings/0001437749-24-031673.md) | [106](/filings/0001437749-25-006453.md) | [91.3](/filings/0001437749-25-015474.md) | [91.3](/filings/0001437749-25-026942.md) | [104](/filings/0001437749-24-031673.md) | [91.3](/filings/0001437749-26-009589.md) | [170](/filings/0001437749-26-015573.md) | [148](/filings/0001437749-25-026942.md) | [176](/filings/0001437749-25-032230.md) | [170](/filings/0001437749-26-024304.md) | [218](/filings/0001437749-26-015573.md) | [194](/filings/0001437749-26-024304.md) |
| Current liabilities | $m | [11.7](/filings/0001120970-23-000072.md) | [14.8](/filings/0001437749-25-006453.md) | [14.8](/filings/0001120970-24-000044.md) | [13.3](/filings/0001437749-24-025555.md) | [12.2](/filings/0001437749-24-031673.md) | [8.1](/filings/0001437749-26-009589.md) | [8.6](/filings/0001437749-25-015474.md) | [15.4](/filings/0001437749-25-026942.md) | [13.8](/filings/0001437749-25-032230.md) | [10.0](/filings/0001437749-26-024304.md) | [17.1](/filings/0001437749-26-015573.md) | [18.2](/filings/0001437749-26-024304.md) |
| Total liabilities | $m | [24.8](/filings/0001120970-23-000072.md) | [28.2](/filings/0001437749-25-006453.md) | [30.9](/filings/0001120970-24-000044.md) | [29.5](/filings/0001437749-24-025555.md) | [35.6](/filings/0001437749-24-031673.md) | [31.5](/filings/0001437749-26-009589.md) | [51.8](/filings/0001437749-25-015474.md) | [56.4](/filings/0001437749-25-026942.md) | [54.6](/filings/0001437749-25-032230.md) | [58.7](/filings/0001437749-26-024304.md) | [58.4](/filings/0001437749-26-015573.md) | [52.9](/filings/0001437749-26-024304.md) |
| Long-term debt | $m | [5.8](/filings/0001120970-23-000072.md) | [5.4](/filings/0001437749-25-006453.md) | [7.9](/filings/0001120970-24-000044.md) | [8.4](/filings/0001437749-24-025555.md) | [10.6](/filings/0001437749-24-031673.md) | [8.4](/filings/0001437749-26-009589.md) | [13.9](/filings/0001437749-25-015474.md) | [8.4](/filings/0001437749-25-026942.md) | [0.0](/filings/0001437749-25-032230.md) | [0.0](/filings/0001437749-26-009589.md) | not reported | not reported |
| Current portion of debt | $m | [0.0](/filings/0001120970-23-000072.md) | [4.5](/filings/0001437749-25-006453.md) | [3.0](/filings/0001120970-24-000044.md) | [1.6](/filings/0001437749-24-025555.md) | [0.6](/filings/0001437749-24-031673.md) | [0.1](/filings/0001437749-26-009589.md) | [0.0](/filings/0001437749-25-015474.md) | [1.8](/filings/0001437749-25-026942.md) | [0.0](/filings/0001437749-25-032230.md) | [0.0](/filings/0001437749-26-009589.md) | not reported | not reported |
| Shareholders' equity | $m | [66.0](/filings/0001120970-23-000072.md) | [78.3](/filings/0001437749-25-006453.md) | [73.8](/filings/0001120970-24-000044.md) | [74.9](/filings/0001437749-24-025555.md) | [68.0](/filings/0001437749-24-031673.md) | [59.8](/filings/0001437749-26-009589.md) | [59.5](/filings/0001437749-26-024304.md) | [88.6](/filings/0001437749-25-026942.md) | [118](/filings/0001437749-25-032230.md) | [108](/filings/0001437749-26-024304.md) | [156](/filings/0001437749-26-015573.md) | [137](/filings/0001437749-26-024304.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.5) d](/filings/0001437749-24-031673.md) | [(2.4) d](/filings/0001437749-25-006453.md) | [(3.8)](/filings/0001437749-25-015474.md) | [(2.0) d](/filings/0001437749-25-026942.md) | [(3.8) d](/filings/0001437749-25-032230.md) | [(4.3) d](/filings/0001437749-26-009589.md) | [(5.0)](/filings/0001437749-26-015573.md) | [(4.8) d](/filings/0001437749-26-024304.md) | [(8.7) d](/filings/0001437749-25-032230.md) | [(5.9) d](/filings/0001437749-26-009589.md) | [(5.8)](/filings/0001437749-26-015573.md) | [(10.1) d](/filings/0001437749-26-024304.md) |
| Capital expenditure | $m | [0.7](/filings/0001120970-23-000072.md) | [0.3 d](/filings/0001120970-24-000014.md) | [0.4](/filings/0001120970-24-000044.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q3 FY2020 (2020-09-30) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q3 FY2024 (2024-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [32.1](/filings/0001120970-21-000112.md) | [37.8](/filings/0001120970-22-000046.md) | [43.1](/filings/0001120970-22-000066.md) | [54.6](/filings/0001120970-22-000078.md) | [67.4](/filings/0001120970-23-000033.md) | [68.7](/filings/0001120970-23-000052.md) | [76.5](/filings/0001120970-23-000072.md) | [94.7](/filings/0001120970-24-000044.md) | [101](/filings/0001120970-23-000052.md) | [110](/filings/0001437749-24-031673.md) | [117](/filings/0001120970-24-000044.md) | [188](/filings/0001437749-24-031673.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 75,993,047 at 2026-07-20, from the cover of the [10-Q filed 2026-07-23](/filings/0001437749-26-024304.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.